Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of nafarelin cas 76932-56-4 in China. Welcome to wholesale bulk high quality nafarelin cas 76932-56-4 for sale here from our factory. Good service and reasonable price are available.
Nafarelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist, belonging to a class of medications used primarily in the treatment of infertility and certain endocrine disorders. It mimics the natural action of GnRH, a hormone produced by the hypothalamus that stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones, in turn, regulate the function of the ovaries and testes, playing a crucial role in reproduction.
In the context of infertility treatment, it is administered nasally, typically as a spray, to induce ovulation in women with conditions such as polycystic ovarian syndrome (PCOS) or those undergoing assisted reproductive technologies like in vitro fertilization (IVF). By stimulating the release of FSH and LH, it helps to mature eggs in the ovaries, increasing the chances of successful fertilization and pregnancy.
Additionally, it has been used in the diagnosis of hypogonadotropic hypogonadism, a condition where the body fails to produce adequate amounts of GnRH, resulting in low levels of sex hormones and impaired sexual development. By provoking a hormonal response, it can help confirm the diagnosis and guide subsequent treatment plans.
However, it use is associated with potential side effects, including headaches, nausea, and nasal irritation. Moreover, it requires careful monitoring and adjustment of dosage to ensure optimal outcomes while minimizing adverse effects. Therefore, it's essential to work closely with a healthcare provider experienced in fertility treatments when considering it as part of a therapeutic regimen.
Customized Bottle Caps & Corks
|
|
|
|
Chemical Formula |
C66H83N17O13 |
|
Exact Mass |
1321.64 |
|
Molecular Weight |
1322.50 |
|
m/z |
1321.64 (100.0%), 1322.64 (71.4%), 1323.64 (25.1%), 1322.63 (5.9%), 1324.65 (5.8%), 1323.64 (4.5%), 1323.64 (2.7%), 1324.64 (1.9%), 1324.64 (1.5%) |
|
Elemental Analysis |
C, 59.94; H, 6.33; N, 18.01; O, 15.73 |
Nafarelin, also known as Synarel, is a synthetic analog of gonadotropin-releasing hormone (GnRH), a naturally occurring hormone in the human body that plays a critical role in regulating the reproductive system. As a pharmaceutical agent, it has specific medical applications, primarily in the treatment of endocrine disorders and in assisted reproductive technologies.
It is most commonly used to treat children with central precocious puberty, a condition where sexual development begins too early, typically before the age of 8 in girls and 9 in boys. By stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in the short term, it ultimately suppresses the hypothalamic-pituitary-gonadal axis, thereby slowing down the onset of puberty and allowing for normal physical and emotional development. However, it's worth noting that is not the first-line treatment for CPP; gonadotropin-releasing hormone analogues (GnRHa) with longer-lasting suppression effects, such as leuprolide or histrelin, are more commonly prescribed.
In some cases, it has been investigated for its potential to induce ovulation in women with certain fertility issues. Though not as widely used as other ovulation-inducing drugs like clomiphene citrate or human chorionic gonadotropin (hCG), it may be considered in select patients under the guidance of a fertility specialist. Its use in this context is more limited and tailored to individual patient needs.
Additionally, it has been used in research settings to investigate the mechanisms of hormonal regulation in the human body, particularly those related to the reproductive system. This includes studies on the effects of GnRH analogs on pituitary function, gonadal hormone secretion, and overall endocrine balance.
mechanism of action
As a synthetic gonadotropin-releasing hormone (GnRH) analogue, its core mechanism of action lies in its highly specific binding to the GnRH receptor in the anterior pituitary gland. This combination is not a simple physical action, but triggers a series of complex intracellular signal transduction processes.
When the substance binds to the GnRH receptor, it activates the receptor and triggers a series of biochemical reactions. These reactions lead to the release and activation of intracellular signaling molecules, which in turn affect gene expression and protein synthesis related to gonadotropin secretion.
Mode of Administration
Nafarelin is typically administered as a nasal spray, allowing for direct absorption into the bloodstream via the nasal mucosa. This route of administration provides a rapid onset of action and enables relatively easy patient self-administration.
Precautions and Side Effects
Like any medication, it can cause side effects, including but not limited to nasal irritation, headaches, hot flashes, vaginal bleeding, and mood changes. It's crucial to use it exactly as prescribed by a healthcare provider and to report any adverse reactions promptly. Long-term use may also lead to bone density loss, requiring regular monitoring in certain patient populations.
Synthesis method
1. Introduction of amino acids:
-Firstly, select appropriate starting amino acids such as alanine, arginine, etc., and introduce them into the reaction system. This can be achieved by first creating Boc protective derivatives of amino acids, followed by nucleophilic substitution reactions to introduce amino acids.
-R-NH2+Boc2O → R-NH Boc+H2O
2. Coupling of amino acids:
-Use appropriate coupling reagents (such as DCC, DIC, etc.) to connect two amino acids through peptide bonds to form dipeptides.
-R1-NH-Boc+R2-COOH → R1-NH-CO-R2+BocOH
3. Remove protective base:
-After the formation of dipeptides, the protective group (Boc protective group) is removed under acidic conditions.
-R-NH-CO-R '+HCl → R-NH-CO-R'+H2O
4. Multi step repetitive reaction:
-Repeat the above steps to gradually construct the polypeptide chain.
-N amino acids are gradually synthesized into polypeptide chains through coupling reactions and deprotection reactions.
5. Final modification:
-After the formation of peptide chains, final modification reactions such as esterification and amidation are carried out to form the structure.
Nafarelin, a pioneering pharmaceutical product from our esteemed company, embodies the pinnacle of innovation and efficacy in the field of hormone therapy. Its primary advantage lies in its precision-targeted approach to stimulating the pituitary gland, naturally releasing gonadotropin-releasing hormone (GnRH), subsequently enhancing gonadotropin secretion. This gentle yet potent mechanism allows for more controlled and individualized treatment options, particularly in the management of infertility, hormone imbalances, and certain endocrine disorders.
One key strength is its rapid onset of action, offering patients swift relief or improvement in symptoms. Its nasal spray delivery system ensures ease of administration and enhanced bioavailability, making it a patient-friendly alternative to traditional injection therapies. Moreover, its side effect profile is generally well-tolerated, minimizing discomfort and improving compliance rates among users.
Our commitment to research and development ensures that remains at the forefront of medical advancements, continuously refining its efficacy and safety profile. The product undergoes rigorous clinical testing to guarantee its quality and effectiveness, instilling trust and confidence in healthcare professionals and patients alike.
Nafarelin,Also known as Nariline or Synarel, it is an analog of gonadotropin-releasing hormone (GnRH). It is rapidly absorbed through nasal administration and is mainly used to treat conditions such as endometriosis, uterine fibroids, and hirsutism. In recent years, with the continuous advancement of medical technology and the increasing awareness of health among people, its market demand as an effective therapeutic drug has continued to grow. The following is a detailed explanation of its development prospects:
Market demand analysis
Population aging and the increase of disease incidence rate
With the aggravation of global population aging, the incidence rate of various chronic diseases is also increasing year by year. Among them, endometriosis, as a common gynecological disease, its incidence rate is particularly prominent in women. According to research, the incidence rate of endometriosis in women of childbearing age is as high as 10% -15%, and shows a rising trend year by year. This trend will directly drive the growth of market demand for related therapeutic drugs.
The improvement of women's health awareness
In recent years, with the continuous improvement of women's health awareness, more and more women have begun to pay attention to their physical condition and actively seek effective treatment methods. As a safe and effective therapeutic drug, its efficacy has been widely recognized. Therefore, with the increasing awareness of women's health, its market demand will also further grow.
New drug development and marketing promotion
With the continuous advancement of pharmaceutical technology, the speed of new drug research and development is also accelerating. Several pharmaceutical companies are actively developing new formulations in order to further improve efficacy and reduce side effects. Meanwhile, the strengthening of market promotion will also provide strong support for its market demand growth. By increasing publicity efforts, expanding sales channels, and other measures, it will help improve the visibility and market share of this compound.
Technological progress and innovation
Improvement of formulation technology
In recent years, with the continuous improvement of formulation technology, its dosage form and administration method have also been continuously optimized. For example, by changing the crystal form, particle size, and other parameters of drugs, the solubility and bioavailability of drugs can be improved; By developing new drug delivery systems, such as nasal sprays and sustained-release preparations, the convenience and comfort of patients can be further improved. The improvement of these formulation technologies will provide a broader space for the clinical application of Nafarelin.
Innovation in drug development
In addition to the improvement of formulation technology, innovation in new drug development is also an important driving force for the development of Nafarelin. Several pharmaceutical companies are actively developing new formulations in order to further improve efficacy and reduce side effects. For example, by changing the chemical structure of drugs or introducing new pharmacophores, new drugs with higher activity and lower toxicity can be developed; By optimizing the metabolic pathways and excretion mechanisms of drugs, the side effects and adverse reactions of drugs can be reduced. The innovation in the development of these new drugs will provide more effective solutions for their clinical applications.
Development Strategy and Suggestions
Strengthen research and development innovation
Enterprises should increase their research and development innovation efforts and continuously launch new drug products with independent intellectual property rights. By optimizing the chemical structure of drugs, enhancing their activity, and reducing their side effects, safer and more effective formulations can be developed. At the same time, enterprises should strengthen cooperation and communication with other research institutions and enterprises to jointly promote the research and development progress of Nafarelin.
Expand sales channels
Enterprises should actively expand their sales channels and increase their market share. By strengthening cooperation and communication with sales channels such as hospitals and pharmacies, establish a comprehensive sales network and after-sales service system. At the same time, enterprises can also use the Internet and e-commerce and other emerging channels for marketing and sales to expand the market coverage of this compound.
Improve product quality and service level
Enterprises should focus on improving product quality and service levels to meet the needs and expectations of patients. By strengthening the construction of quality management system and improving the level of production technology, ensure its quality and safety. At the same time, enterprises should strengthen the construction of customer service system, provide high-quality after-sales service and patient education services, in order to improve patient satisfaction and loyalty with medication.
Pay attention to policy developments and changes in market demand
Enterprises should closely monitor policy developments and changes in market demand, and adjust their market strategies and product layouts in a timely manner. By strengthening communication and collaboration with government departments, we can understand policy trends and market demand changes. At the same time, enterprises should strengthen market research and analysis work, grasp market dynamics and competitive situations, and provide strong support for formulating scientific market strategies.
Hot Tags: nafarelin cas 76932-56-4, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, CAS 1674334 59 8, Cosmetic, 4 4 naphthalene 1 2 diylbis 4 1 phenylene bis 2 phenylbenzo h quinazoline , 4 4 5 5 tetramethyl 2 triphenylen 2 yl 1 3 2 dioxaborolane, Cosmetic, tetracaine hcl powder